H. Willert, H. Bertram, and G. Buchhorn, Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles, Clin Orthop Relat Res, vol.258, pp.95-107, 1990.

E. Schwarz, O. Keefe, R. Looney, and R. , Bone implant interface, osteolysis and potential therapies, J Musculoskelet Neuronal Interact, vol.4, pp.390-392, 2004.

S. Kobayashi, K. Takaoka, N. Saito, and K. Hisa, Factors Affecting Aseptic Failure of Fixation after Primary Charnley Total Hip Arthroplasty, The Journal of Bone and Joint Surgery (American Volume), vol.79, issue.11, pp.1618-1627, 1997.
DOI : 10.2106/00004623-199711000-00002

M. Von-knoch, D. Jewison, J. Sibonga, R. Turner, B. Morrey et al., Decrease in particle-induced osteolysis in obese (ob/ob) mice, Biomaterials, vol.25, issue.19, pp.4675-4681, 2004.
DOI : 10.1016/j.biomaterials.2004.02.069

C. Zhang, T. Tang, W. Ren, X. Zhang, and K. Dai, Influence of mouse genetic background on wear particle-induced in vivo inflammatory osteolysis, Inflammation Research, vol.57, issue.5, pp.211-215, 2008.
DOI : 10.1007/s00011-007-7040-3

C. Nich, A. Marchadier, L. Sedel, H. Petite, C. Vidal et al., Decrease in particle-induced osteolysis in ovariectomized mice, Journal of Orthopaedic Research, vol.55, pp.178-183, 2010.
DOI : 10.1002/jor.20987

N. Ishiguro, T. Kojima, T. Ito, S. Saga, H. Anma et al., Macrophage activation and migration in interface tissue around loosening total hip arthroplasty components, Journal of Biomedical Materials Research, vol.274, issue.3, pp.399-406, 1997.
DOI : 10.1002/(SICI)1097-4636(19970605)35:3<399::AID-JBM14>3.0.CO;2-A

T. Green, J. Fisher, J. Matthews, M. Stone, and E. Ingham, Effect of size and dose on bone resorption activity of macrophages byin vitro clinically relevant ultra high molecular weight polyethylene particles, Journal of Biomedical Materials Research, vol.14, issue.5, pp.490-497, 2000.
DOI : 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7

K. Tat, S. Padrines, M. Theoleyre, S. Heymann, D. Fortun et al., IL-6, RANKL, TNFalpha/IL-1: interrelations in bone resorption pathophysiology, Cytokine Growth Factor Rev, vol.15, pp.49-60, 2004.

T. Wronski, L. Dann, K. Scott, and M. Cintrón, Long-term effects of ovariectomy and aging on the rat skeleton, Calcified Tissue International, vol.29, issue.6, pp.360-366, 1989.
DOI : 10.1007/BF02556007

G. Passeri, G. Girasole, R. Jilka, and S. Manolagas, Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal, Endocrinology, vol.133, pp.822-828, 1993.

T. Spelsberg, M. Subramaniam, B. Riggs, and S. Khosla, The Actions and Interactions of Sex Steroids and Growth Factors/Cytokines on the Skeleton, Molecular Endocrinology, vol.13, issue.6, pp.819-828, 1999.
DOI : 10.1210/mend.13.6.0299

R. Müller, H. Van-campenhout, B. Van-damme, G. Van-der-perre, J. Dequeker et al., Morphometric Analysis of Human Bone Biopsies: A Quantitative Structural Comparison of Histological Sections and Micro-Computed Tomography, Bone, vol.23, issue.1, pp.59-66, 1998.
DOI : 10.1016/S8756-3282(98)00068-4

H. Van-den-brink, A. Van-everdingen, M. Van-wijk, J. Jacobs, and J. Bijlsma, Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis., Annals of the Rheumatic Diseases, vol.52, issue.12, pp.862-865, 1993.
DOI : 10.1136/ard.52.12.862

G. Hall, M. Daniels, E. Huskisson, and T. Spector, A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis., Annals of the Rheumatic Diseases, vol.53, issue.2, pp.112-116, 1994.
DOI : 10.1136/ard.53.2.112

D. Elia, H. Mattsson, L. Ohlsson, C. Nordborg, E. Carlsten et al., Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1, Arthritis Research & Therapy, vol.5, issue.4, pp.202-209, 2003.
DOI : 10.1186/ar761

T. Yoneda, N. Ishimaru, R. Arakaki, M. Kobayashi, T. Izawa et al., Estrogen Deficiency Accelerates Murine Autoimmune Arthritis Associated with Receptor Activator of Nuclear Factor-??B Ligand-Mediated Osteoclastogenesis, Endocrinology, vol.145, issue.5, pp.2384-2391, 2004.
DOI : 10.1210/en.2003-1536

S. Subramanian, M. Tovey, M. Afentoulis, A. Krogstad, A. Vandenbark et al., Ethinyl estradiol treats collagen-induced arthritis in DBA/1LacJ mice by inhibiting the production of TNF-?? and IL-1??, Clinical Immunology, vol.115, issue.2, pp.162-172, 2005.
DOI : 10.1016/j.clim.2005.01.006

J. Da-silva and D. Willoughby, The influence of sex in arthritis: is cartilage an overlooked factor?, J Rheumatol, vol.21, pp.791-796, 1994.

R. Kimble, S. Srivastava, F. Ross, A. Matayoshi, and R. Pacifici, Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factormediated stimulation of macrophage colony-stimulating factor production, J Biol Chem, vol.271, pp.28890-28897, 1996.

Y. Kong, U. Feige, I. Sarosi, B. Bolon, A. Tafuri et al., Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand, Nature, vol.402, pp.304-309, 1999.

J. Li, I. Sarosi, X. Yan, S. Morony, C. Capparelli et al., RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism, Proceedings of the National Academy of Sciences, vol.97, issue.4, pp.1566-1571, 2000.
DOI : 10.1073/pnas.97.4.1566

S. Teitelbaum, Osteoclasts, integrins, and osteoporosis, Journal of Bone and Mineral Metabolism, vol.18, issue.6, pp.344-349, 2000.
DOI : 10.1007/s007740070007

T. Nakamura, Y. Imai, T. Matsumoto, S. Sato, K. Takeuchi et al., Estrogen Prevents Bone Loss via Estrogen Receptor ?? and Induction of Fas Ligand in Osteoclasts, Cell, vol.130, issue.5, pp.811-823, 2007.
DOI : 10.1016/j.cell.2007.07.025

URL : https://hal.archives-ouvertes.fr/hal-00188977

L. Childs, J. Goater, O. Keefe, R. Schwarz, and E. , Efficacy of Etanercept for Wear Debris-Induced Osteolysis, Journal of Bone and Mineral Research, vol.95, issue.Suppl, pp.338-347, 2001.
DOI : 10.1359/jbmr.2001.16.2.338

Y. Zhang, A. Heulsmann, M. Tondravi, A. Mukherjee, and Y. Abu-amer, Tumor Necrosis Factor-alpha (TNF) Stimulates RANKL-induced Osteoclastogenesis via Coupling of TNF Type 1 Receptor and RANK Signaling Pathways, Journal of Biological Chemistry, vol.276, issue.1, pp.563-568, 2001.
DOI : 10.1074/jbc.M008198200

R. Kimble, A. Matayoshi, J. Vannice, V. Kung, C. Williams et al., Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period, Endocrinology, vol.136, pp.3054-3061, 1995.

C. Roggia, Y. Gao, S. Cenci, M. Weitzmann, G. Toraldo et al., Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo, Proceedings of the National Academy of Sciences, vol.98, issue.24, pp.13960-13965, 2001.
DOI : 10.1073/pnas.251534698

N. Taki, J. Tatro, R. Lowe, V. Goldberg, and E. Greenfield, Comparison of the roles of IL-1, IL-6, and TNF?? in cell culture and murine models of aseptic loosening, Bone, vol.40, issue.5, pp.1276-1283, 2007.
DOI : 10.1016/j.bone.2006.12.053

U. Lerner, Inflammation-induced Bone Remodeling in Periodontal Disease and the Influence of Post-menopausal Osteoporosis, Journal of Dental Research, vol.85, issue.7, pp.596-607, 2006.
DOI : 10.1177/154405910608500704

J. Lorenzo, Interactions between immune and bone cells: new insights with many remaining questions, Journal of Clinical Investigation, vol.106, issue.6, pp.749-752, 2000.
DOI : 10.1172/JCI11089

P. Hernigou, L. Intrator, T. Bahrami, A. Bensussan, and J. Farcet, Interleukin-6 in the Blood of Patients With Total Hip Arthroplasty Without Loosening, Clinical Orthopaedics and Related Research, vol.366, pp.147-154, 1999.
DOI : 10.1097/00003086-199909000-00018

R. Tanaka, Y. Yasunaga, T. Hisatome, T. Yamasaki, H. Iwamori et al., Serum Interleukin 8 Levels Correlate With Synovial Fluid Levels in Patients With Aseptic Loosening of Hip Prosthesis, The Journal of Arthroplasty, vol.20, issue.8, pp.1049-1054, 2005.
DOI : 10.1016/j.arth.2005.03.034

S. Cenci, M. Weitzmann, C. Roggia, N. Namba, D. Novack et al., Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-??, Journal of Clinical Investigation, vol.106, issue.10, pp.1229-1237, 2000.
DOI : 10.1172/JCI11066

M. Weitzmann and R. Pacifici, The role of T lymphocytes in bone metabolism, Immunological Reviews, vol.37, issue.1, pp.154-168, 2005.
DOI : 10.1016/S0092-8674(00)81109-5

R. Pacifici, Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis, Journal of Bone and Mineral Research, vol.10, issue.Suppl 1, pp.1043-1051, 1996.
DOI : 10.1002/jbmr.5650110802

T. Sato, K. Watanabe, M. Masuhara, N. Hada, and Y. Hakeda, Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro, Journal of Bone and Mineral Metabolism, vol.33, issue.1, pp.19-27, 2007.
DOI : 10.1007/s00774-006-0723-y

K. Kim, J. Zhao, S. Auh, X. Yang, P. Du et al., Adaptive immune cells temper initial innate responses, Nat Med, vol.13, pp.1248-1252, 2007.

G. Guarda, C. Dostert, F. Staehli, K. Cabalzar, R. Castillo et al., T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes, Nature, vol.5, issue.7252, pp.269-273, 2009.
DOI : 10.1038/nature08100

V. Everts, T. De-vries, and M. Helfrich, Osteoclast heterogeneity:, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1792, issue.8, pp.757-765, 2009.
DOI : 10.1016/j.bbadis.2009.05.004

URL : https://hal.archives-ouvertes.fr/hal-00506512

A. De-souza-faloni, T. Schoenmaker, A. Azari, E. Katchburian, P. Cerri et al., Jaw and Long Bone Marrows Have a Different Osteoclastogenic Potential, Calcified Tissue International, vol.38, issue.1, pp.63-74, 2011.
DOI : 10.1007/s00223-010-9418-4

V. Everts, W. Korper, K. Hoeben, I. Jansen, D. Bromme et al., Osteoclastic Bone Degradation and the Role of Different Cysteine Proteinases and Matrix Metalloproteinases: Differences Between Calvaria and Long Bone, Journal of Bone and Mineral Research, vol.1, issue.9, pp.1399-1408, 2006.
DOI : 10.1359/jbmr.060614

S. Perez-amodio, D. Jansen, T. Schoenmaker, I. Vogels, T. Reinheckel et al., Calvarial Osteoclasts Express a Higher Level of Tartrate-Resistant Acid Phosphatase than Long Bone Osteoclasts and Activation Does not Depend on Cathepsin K or L Activity, Calcified Tissue International, vol.878, issue.suppl, pp.245-254, 2006.
DOI : 10.1007/s00223-005-0289-z

T. Van-de-bos, D. Speijer, R. Bank, D. Bromme, and V. Everts, Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption, Bone, vol.43, issue.3, pp.459-468, 2008.
DOI : 10.1016/j.bone.2008.05.009

H. Libouban, M. Moreau, M. Baslé, R. Bataille, and D. Chappard, Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model, Bone, vol.33, issue.3, pp.283-292, 2003.
DOI : 10.1016/S8756-3282(03)00196-0

S. Takata, S. Takao, S. Yoshida, F. Hayashi, and N. Yasui, Therapeutic effects of one-year alendronate treatment in three cases of osteoporosis with parietal thinning of skull, The Journal of Medical Investigation, vol.55, issue.3,4, pp.297-302, 2008.
DOI : 10.2152/jmi.55.297